PD-L1 Anticorps
(CD274 (PD-L1))
Choisissez l’un des 462 anticorps PD-L1 de notre liste de produits basés sur 9 publications et 153 images de validation.
Découvrez des anticorps PD-L1 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de PD-L1 dans plusieurs espèces, y compris Human, Mouse, Rat, Non-Human Primate, Monkey, Cow, Pig, Cynomolgus, Cat, Dog, Horse, et prend en charge diverses applications de recherche telles que WB, FACS, ELISA, IHC, IF.
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants PD-L1, issus de différents hôtes tels que Rabbit, Mouse, Rat. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de PD-L1 sont CD274, Cd274, PDCD1LG2.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| PD-L1 anticorps (AA 34-241) | Rat | Souris Monoclonal |
|
327,78 €
Voir le prix
|
|
| PD-L1 anticorps (AA 24-234) | Humain | Souris Monoclonal |
|
307,75 €
Voir le prix
|
|
| Recombinant PD-L1 anticorps | Humain | Lapin Monoclonal |
|
385,00 €
Voir le prix
|
|
| PD-L1 anticorps (AA 39-191) (PE) | Humain, Souris | Souris Monoclonal |
|
639,45 €
Voir le prix
|
|
| PD-L1 anticorps (full length) | Humain, Non-Human Primate | Souris Monoclonal |
|
279,31 €
Voir le prix
|
|
| PD-L1 anticorps (full length) (APC) | Humain, Non-Human Primate | Souris Monoclonal |
|
418,97 €
Voir le prix
|
|
| PD-L1 anticorps (full length) | Humain, Non-Human Primate | Souris Monoclonal |
|
279,31 €
Voir le prix
|
|
| PD-L1 anticorps (full length) (FITC) | Humain, Non-Human Primate | Souris Monoclonal |
|
356,73 €
Voir le prix
|
|
| PD-L1 anticorps (AA 201-290) | Souris | Lapin Polyclonal |
|
357,70 €
Voir le prix
|
|
| PD-L1 anticorps (AA 141-240) | Humain | Souris Polyclonal |
|
508,80 €
Voir le prix
|
|
| Recombinant PD-L1 anticorps | Humain | Human Monoclonal |
|
500,00 €
Voir le prix
|
|
| PD-L1 anticorps (AA 19-328) | Humain | Lapin Monoclonal |
|
857,23 €
Voir le prix
|
|
| PD-L1 anticorps (Extracellular Domain) | Humain | Souris Monoclonal |
|
701,54 €
Voir le prix
|
|
| PD-L1 anticorps (AA 34-241) | Souris | Lapin Polyclonal |
|
478,68 €
Voir le prix
|
|
| PD-L1 anticorps (AA 45-290) | Humain | Lapin Polyclonal |
|
522,50 €
Voir le prix
|
|
| PD-L1 anticorps (PE-Cy7) | Souris | Rat Monoclonal |
|
500,00 €
Voir le prix
|
|
| Recombinant PD-L1 anticorps (AA 19-239) | Souris | Lapin Monoclonal |
|
430,15 €
Voir le prix
|
|
| Recombinant PD-L1 anticorps (AA 19-238) | Humain | Lapin Monoclonal |
|
430,15 €
Voir le prix
|
|
| PD-L1 anticorps (AA 261-290) | Humain | Lapin Polyclonal |
|
512,07 €
Voir le prix
|
|
| PD-L1 anticorps (AA 192-241) | Humain, Porc, Boeuf (Vache) | Lapin Polyclonal |
|
789,41 €
Voir le prix
|
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- IHC (Immunohistochemistry: Image de validation disponible)
- Reactivité
- Rat
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- D6
- Conjugué
- unconjugated
- Isotype
- IgG2a kappa
- Epitope
- AA 34-241
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- IHC (Immunohistochemistry: Image de validation disponible)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- C1
- Conjugué
- unconjugated
- Isotype
- IgG1 kappa
- Epitope
- AA 24-234
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- IHC (Immunohistochemistry: Image de validation disponible)
- ELISA (ELISA: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Monoclonal
- Clone
- 10D4
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG
Primary Antibody
- FACS (Flow Cytometry: Image de validation disponible)
- SDS (SDS-PAGE: Image de validation disponible)
- IF (Immunofluorescence: Application indiquée)
- Reactivité
- Humain, Souris
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- PDL1-2746
- Conjugué
- PE
- Isotype
- IgG2b kappa
- Epitope
- AA 39-191
Primary Antibody
- FACS (Flow Cytometry: Image de validation disponible)
- Func (Functional Studies: Application indiquée)
- IHC (fro) (Immunohistochemistry (Frozen Sections): Application indiquée)
- Reactivité
- Humain, Non-Human Primate
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 29E-2A3
- Conjugué
- unconjugated
- Isotype
- IgG2b, kappa
- Epitope
- full length
Primary Antibody
- FACS (Flow Cytometry: Image de validation disponible)
- Reactivité
- Humain, Non-Human Primate
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 29E-2A3
- Conjugué
- APC
- Isotype
- IgG2b, kappa
- Epitope
- full length
Primary Antibody
- FACS (Flow Cytometry: Image de validation disponible)
- IHC (fro) (Immunohistochemistry (Frozen Sections): Application indiquée)
- Reactivité
- Humain, Non-Human Primate
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 29E-2A3
- Conjugué
- unconjugated
- Isotype
- IgG2b, kappa
- Epitope
- full length
Primary Antibody
- FACS (Flow Cytometry: Image de validation disponible)
- Reactivité
- Humain, Non-Human Primate
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- 29E-2A3
- Conjugué
- FITC
- Isotype
- IgG2b, kappa
- Epitope
- full length
Primary Antibody
- IHC (Immunohistochemistry: Image de validation disponible)
- ELISA (ELISA: Image de validation disponible)
- WB (Western Blotting: Application indiquée)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Application indiquée)
- IF (cc) (Immunofluorescence (Cultured Cells): Application indiquée)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): Application indiquée)
- IHC (fro) (Immunohistochemistry (Frozen Sections): Application indiquée)
- Reactivité
- Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 201-290
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- AA 141-240
Primary Antibody
- SDS (SDS-PAGE: Image de validation disponible)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Image de validation disponible)
- FACS (Flow Cytometry: Application indiquée)
- ELISA (ELISA: Application indiquée)
- Func (Functional Studies: Application indiquée)
- BLI (Bio-Layer Interferometry: Application indiquée)
- SPR (Surface Plasmon Resonance: Application indiquée)
- Reactivité
- Humain
- Hôte
- Human
- Clonalité
- Monoclonal
- Clone
- MDX-1105
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG4 S228P
Primary Antibody
- FACS (Flow Cytometry: Image de validation disponible)
- ELISA (ELISA: Image de validation disponible)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Monoclonal
- Clone
- DM123
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 19-328
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- IHC (Immunohistochemistry: Image de validation disponible)
- PAr (Protein Array: Image de validation disponible)
- SDS (SDS-PAGE: Image de validation disponible)
- Reactivité
- Humain
- Hôte
- Souris
- Clonalité
- Monoclonal
- Clone
- PDL1-2746
- Conjugué
- unconjugated
- Isotype
- IgG2b kappa
- Epitope
- AA 39-191, Extracellular Domain
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Image de validation disponible)
- IHC (Immunohistochemistry: Application indiquée)
- IP (Immunoprecipitation: Application indiquée)
- IF/ICC (Immunofluorescence (fixed cells): Application indiquée)
- Reactivité
- Souris
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- AA 34-241
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- FACS (Flow Cytometry: Image de validation disponible)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Isotype
- IgG
- Epitope
- AA 45-290
Primary Antibody
- FACS (Flow Cytometry: Image de validation disponible)
- Reactivité
- Souris
- Hôte
- Rat
- Clonalité
- Monoclonal
- Clone
- 10F-9G2
- Conjugué
- PE-Cy7
- Isotype
- IgG2b kappa
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- Reactivité
- Souris
- Hôte
- Lapin
- Clonalité
- Monoclonal
- Clone
- BLR226K
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG
- Epitope
- AA 19-239
Primary Antibody
- WB (Western Blotting: Image de validation disponible)
- FACS (Flow Cytometry: Image de validation disponible)
- IP (Immunoprecipitation: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Monoclonal
- Clone
- BLR227K
- Conjugué
- unconjugated
- Type Proteine
- Recombinant Antibody
- Isotype
- IgG
- Epitope
- AA 19-238
Primary Antibody
- IHC (Immunohistochemistry: Image de validation disponible)
- WB (Western Blotting: Application indiquée)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- AA 261-290
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain, Porc, Boeuf (Vache)
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- unconjugated
- Epitope
- AA 192-241
Dernières publications pour nos PD-L1 Anticorps
: "Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin." dans: PLoS ONE, Vol. 16, Issue 1, pp. e0245581, (2021) (PubMed).
: "Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma." dans: Frontiers in oncology, Vol. 11, pp. 757919, (2021) (PubMed).
: "Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder." dans: Journal of clinical medicine, Vol. 9, Issue 5, (2020) (PubMed).
: "NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer." dans: Nature communications, Vol. 11, Issue 1, pp. 1669, (2020) (PubMed).
: "Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer." dans: PLoS ONE, Vol. 15, Issue 3, pp. e0230449, (2020) (PubMed).
: "MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma." dans: Aging, Vol. 12, Issue 2, pp. 1213-1236, (2020) (PubMed).
: "Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway. ..." dans: Cancer immunology research, Vol. 7, Issue 5, pp. 841-852, (2019) (PubMed).
: "Autophagy inhibition enhances PD-L1 expression in gastric cancer." dans: Journal of experimental & clinical cancer research : CR, Vol. 38, Issue 1, pp. 140, (2019) (PubMed).
: "Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy." dans: PLoS ONE, Vol. 14, Issue 5, pp. e0215990, (2019) (PubMed).
: "Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy." dans: Journal of controlled release : official journal of the Controlled Release Society, Vol. 308, pp. 29-43, (2019) (PubMed).
: "Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma." dans: Frontiers in oncology, Vol. 11, pp. 757919, (2021) (PubMed).
: "Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder." dans: Journal of clinical medicine, Vol. 9, Issue 5, (2020) (PubMed).
: "NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer." dans: Nature communications, Vol. 11, Issue 1, pp. 1669, (2020) (PubMed).
: "Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer." dans: PLoS ONE, Vol. 15, Issue 3, pp. e0230449, (2020) (PubMed).
: "MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma." dans: Aging, Vol. 12, Issue 2, pp. 1213-1236, (2020) (PubMed).
: "Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway. ..." dans: Cancer immunology research, Vol. 7, Issue 5, pp. 841-852, (2019) (PubMed).
: "Autophagy inhibition enhances PD-L1 expression in gastric cancer." dans: Journal of experimental & clinical cancer research : CR, Vol. 38, Issue 1, pp. 140, (2019) (PubMed).
: "Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy." dans: PLoS ONE, Vol. 14, Issue 5, pp. e0215990, (2019) (PubMed).
: "Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy." dans: Journal of controlled release : official journal of the Controlled Release Society, Vol. 308, pp. 29-43, (2019) (PubMed).
Pseudonymes pour PD-L1 Anticorps
CD274 molecule (CD274) AnticorpsCD274 antigen (Cd274) Anticorps
programmed cell death 1 ligand 2 (PDCD1LG2) Anticorps
CD274 molecule (Cd274) Anticorps
A530045L16Rik Anticorps
B7-H Anticorps
B7H1 Anticorps
B7h1 Anticorps
PD-L1 Anticorps
PDCD1L1 Anticorps
Pdcd1l1 Anticorps
PDCD1LG1 Anticorps
Pdcd1lg1 Anticorps
PDL1 Anticorps
Pdl1 Anticorps
RGD1566211 Anticorps
Avez-vous cherché autre chose?
- PCYT2 Anticorps
- PCYOX1L Anticorps
- PCYOX1 Anticorps
- PCTP Anticorps
- PCSK7 Anticorps
- PCSK6 Anticorps
- PCSK5 Anticorps
- PCSK4 Anticorps
- PCSK2 Anticorps
- PCSK1N Anticorps
- PCSK1 Anticorps
- PCP4 Anticorps
- Pcp2 Anticorps
- PCOTH Anticorps
- PCOLCE2 Anticorps
- PCOLCE Anticorps
- PCNXL2 Anticorps
- PCNT Anticorps
- PCNP Anticorps
- PCMTD1 Anticorps
- PDAP1 Anticorps
- PDCD11 Anticorps
- PDCD2 Anticorps
- PDCD2L Anticorps
- PDCD5 Anticorps
- PDCD6 Anticorps
- PDCD7 Anticorps
- PDCL2 Anticorps
- PDCL3 Anticorps
- PDE10A Anticorps
- PDE11A Anticorps
- PDE12 Anticorps
- PDE1A Anticorps
- PDE1B Anticorps
- PDE1C Anticorps
- PDE2A Anticorps
- PDE3A Anticorps
- PDE3B Anticorps
- PDE4A Anticorps
- PDE4B Anticorps
Vous êtes ici:
